.RESEARCH STUDY FEATURE.06 August 2024.
A big randomized regulated trial with cisgender girls highlights the problems of fidelity to a daily dental preexposure prevention program and also demonstrates that twice-yearly shot of lenacapavir can easily sustain efficient HIV deterrence levels over 6 months.